As of late 2025, the prediction is only partially playing out and it’s too early to declare it clearly right or wrong.

Pricing: Direct‑to‑consumer full‑body MRI providers like Prenuvo and Ezra still commonly charge well above $1,000 per full‑body scan (e.g., Prenuvo around $2,499+; Ezra $1,350–$2,695 in many offerings). (bodyspec.com) However, in May 2025 Function Health’s acquisition of Ezra introduced a full‑body MRI scan marketed at $499, explicitly framed as a big drop from prior ~$1,500 pricing. (prnewswire.com) So the price floor Jason imagined ($500–$1,000) is just beginning to appear, but is not yet the norm across the market.

Adoption: Usage remains niche. Prenuvo reports roughly 150,000 scans total since 2018, which is tiny relative to the general population, and coverage is largely limited to affluent or highly health‑conscious consumers. (axios.com) Major medical organizations and mainstream health outlets still do not recommend full‑body MRI as a routine screening tool for asymptomatic people, citing high cost, false positives, and lack of proven outcome benefit. (verywellhealth.com) That is far from “everybody’s doing it.”

AI‑driven early detection: This part of the vision is materializing. Companies such as Ezra use FDA‑cleared AI (e.g., Ezra Flash and related tools) to speed scans, clean images, and assist in analysis and reporting, explicitly positioning the service as AI‑enabled early cancer/condition detection. (ezra.com) Function Health + Ezra also frame their $499 scan as combining large‑scale lab and imaging data to enable predictive, preventive care. (prnewswire.com)

Because the price trend and AI usage are moving in the predicted direction, but widespread general‑population adoption plainly has not happened and no clear time horizon was given, the fairest assessment as of 2025‑11‑30 is that the prediction’s ultimate outcome is still inconclusive (too early to tell).